trofosfamide has been researched along with Local Neoplasm Recurrence in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Göbel, U; Laws, HJ; Pape, H; Paulussen, M; van Kaick, B | 1 |
| Bechrakis, NE; Coupland, SE; Jahnke, K; Komm, J; Korfel, A; Stein, H; Thiel, E | 1 |
| Hartmann, JT; Kanz, L; Kopp, HG | 1 |
| Debruyne, PR; Demey, W; Dumez, H; Gillis, L; Schöffski, P; Sciot, R | 1 |
| Albrecht, M; Jepsen, G; Thomsen, K; Trams, G | 1 |
| Norum, J | 1 |
| Deininger, MH; Grote, E; Meyermann, R; Wickboldt, J | 1 |
1 trial(s) available for trofosfamide and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Intraocular lymphoma 2000-2005: results of a retrospective multicentre trial.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Brain Neoplasms; Cyclophosphamide; Eye Neoplasms; Female; Humans; Ifosfamide; Lymphoma; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Radiotherapy, Adjuvant; Retinal Neoplasms; Retrospective Studies; Surveys and Questionnaires; Survival Rate; Vitreous Body | 2006 |
6 other study(ies) available for trofosfamide and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Relapse after high-dose therapy in relapsed Ewing's tumor patients: effects of maintenance chemotherapy in two selected patients?
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Bone Neoplasms; Child; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Radiotherapy Dosage; Radiotherapy, Adjuvant; Retreatment; Sarcoma, Ewing | 2003 |
Complete remission of relapsing high-grade angiosarcoma with single-agent metronomic trofosfamide.
Topics: Administration, Oral; Antineoplastic Agents, Alkylating; Cyclophosphamide; Female; Hemangiosarcoma; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Remission Induction | 2006 |
Recurrent low- to intermediate-grade chondrosarcoma of the thumb with lung metastases: an objective response to trofosfamide.
Topics: Aged; Antineoplastic Agents, Alkylating; Bone Neoplasms; Carpometacarpal Joints; Chemotherapy, Adjuvant; Chondrosarcoma; Combined Modality Therapy; Cyclophosphamide; Female; Follow-Up Studies; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Remission Induction; Thumb; Tomography, X-Ray Computed | 2007 |
[Ancillary chemotherapy with trofosfamid, methotrexate and fluoro-uracil in cancer of the breast (author's transl)].
Topics: Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Methotrexate; Neoplasm Metastasis; Neoplasm Recurrence, Local | 1981 |
Complete remission after repeated trofosfamide treatment in relapsing high-grade malignant non-Hodgkin's lymphoma--a case report.
Topics: Antineoplastic Agents; Cyclophosphamide; Female; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Neoplasm Recurrence, Local; Remission Induction | 1994 |
Distinct radiochemotherapy protocols differentially influence cellular proliferation and expression of p53 and Bcl-2 in glioblastoma multiforme relapses in vivo.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Biomarkers; Brain Neoplasms; Cell Division; Chemotherapy, Adjuvant; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Disease Progression; Female; Gene Expression Regulation, Neoplastic; Genes; Genes, bcl-2; Glioblastoma; GTP-Binding Proteins; Humans; Ki-67 Antigen; Life Tables; Lomustine; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplastic Stem Cells; Nimustine; Protein Glutamine gamma Glutamyltransferase 2; Proto-Oncogene Proteins c-bcl-2; Radiotherapy, Adjuvant; Survival Analysis; Teniposide; Transglutaminases; Tumor Suppressor Protein p53 | 2000 |